The Potential Role of <i>POR*28</i> and <i>CYP1A2*F</i> Genetic Variations and Lifestyle Factors on Clozapine and N-DesmethylClozapine Plasma Levels in Schizophrenia Patients-Reference-Cited by-同舟云学术

The Potential Role of POR*28 and CYP1A2*F Genetic Variations and Lifestyle Factors on Clozapine and N-DesmethylClozapine Plasma Levels in Schizophrenia Patients

Published:2023-05-04 Issue:5 Volume:19 Page:319-327
ISSN:1742-5255
Container-title:Expert Opinion on Drug Metabolism & Toxicology
language:en
Short-container-title:Expert Opinion on Drug Metabolism & Toxicology

Author:

Demirbugen Oz Merve¹^ORCID,Ozdemir Fezile²^ORCID,Tok Kenan Can³^ORCID,Dural Emrah⁴^ORCID,Kir Yagmur⁵^ORCID,Ulusoy Muge⁶^ORCID,Gumustas Mehmet³^ORCID,Baskak Bora⁶^ORCID,Suzen H. Sinan¹^ORCID

Affiliation:

1. Faculty of Pharmacy, Department of Pharmaceutical Toxicology, Ankara University, Ankara, Turkey

2. Dr Fazil Kucuk Faculty of Medicine, Eastern Mediterranean University, North Cyprus,Turkey

3. Institute of Forensic Sciences, Department of Forensic Toxicology, Ankara University, Ankara, Turkey

4. Faculty of Pharmacy, Department of Pharmaceutical Toxicology, Sivas Cumhuriyet University, Sivas, Turkey

5. Bursa Acibadem Hospital, Department of Psychiatry, Bursa, Turkey

6. School of Medicine, Department of Psychiatry, Ankara University, Ankara, Turkey

Funder

Ankara University Scientific Projects Coordination Unit

Publisher

Informa UK Limited

Subject

Pharmacology,Toxicology,General Medicine

Link

https://www.tandfonline.com/doi/pdf/10.1080/17425255.2023.2221849

Reference46 articles.

1. Effectiveness of Clozapine Versus Olanzapine, Quetiapine, and Risperidone in Patients With Chronic Schizophrenia Who Did Not Respond to Prior Atypical Antipsychotic Treatment

2. Effectiveness of Second-Generation Antipsychotics in Patients With Treatment-Resistant Schizophrenia: A Review and Meta-Analysis of Randomized Trials

3. Comparative efficacy and tolerability of 32 oral antipsychotics for the acute treatment of adults with multi-episode schizophrenia: a systematic review and network meta-analysis

4. Treatment-resistant schizophrenia: current insights on the pharmacogenomics of antipsychotics